Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
PUT
Tandem Diabetes Care
TNDM
$1.49B
| $11M | ﹤0.01% |
112,500
+1,700
| +2% | +$152K |
|
2727
Zimmer Biomet
ZBH
$19B
| $10.9M | ﹤0.01% |
70,120
+46,746
| +200% | +$7.57M |
|
2728
KeyCorp
KEY
$23.5B
| $10.9M | ﹤0.01% |
530,083
-42,624
| -7% | -$925K |
|
|
CALY
2729
PUT
Callaway Golf Company
CALY
$2.76B
| $10.9M | ﹤0.01% |
324,400
-131,400
| -29% | -$4.22M |
|
2730
PUT
MarketAxess Holdings
MKTX
$5.72B
| $10.9M | ﹤0.01% |
23,600
-1,500
| -6% | -$714K |
|
2731
CALL
Red Rock Resorts
RRR
$3.45B
| $10.9M | ﹤0.01% |
257,400
-328,400
| -56% | -$13M |
|
|
SKX
2732
PUT
DELISTED
Skechers
SKX
| $10.9M | ﹤0.01% |
219,400
+2,500
| +1% | +$118K |
|
2733
CALL
KE Holdings
BEKE
$19.6B
| $10.9M | ﹤0.01% |
229,200
-223,300
| -49% | -$11.4M |
|
2734
ImmunityBio
IBRX
$8.9B
| $10.9M | ﹤0.01% |
765,181
+294,954
| +63% | +$4.87M |
|
2735
CALL
Gold Fields
GFI
$42.8B
| $10.9M | ﹤0.01% |
1,227,000
+795,400
| +184% | +$8.24M |
|
2736
Ross Stores
ROST
$73.7B
| $10.9M | ﹤0.01% |
88,051
-11,221
| -11% | -$1.4M |
|
|
ITCI
2737
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.9M | ﹤0.01% |
267,277
+41,028
| +18% | +$1.52M |
|
2738
Cheesecake Factory
CAKE
$5.48B
| $10.9M | ﹤0.01% |
201,306
+45,925
| +30% | +$2.66M |
|
2739
Cummins
CMI
$79B
| $10.9M | ﹤0.01% |
44,705
-21,399
| -32% | -$5.47M |
|
2740
Aptiv
APTV
$9.43B
| $10.9M | ﹤0.01% |
69,258
+12,477
| +22% | +$1.83M |
|
2741
Scorpio Tankers
STNG
$3.88B
| $10.9M | ﹤0.01% |
493,555
+21,782
| +5% | +$442K |
|
2742
US Foods
USFD
$23.3B
| $10.8M | ﹤0.01% |
282,509
+58,788
| +26% | +$2.28M |
|
|
KYNB
2743
PUT
Kyntra Bio
KYNB
$32.4M
| $10.8M | ﹤0.01% |
16,272
+8,232
| +102% | +$4.74M |
|
|
HZNP
2744
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.8M | ﹤0.01% |
115,605
-297,796
| -72% | -$27.4M |
|
|
HDV
2745
CALL
iShares Core High Dividend ETF
HDV
$15.2B
| $10.8M | ﹤0.01% |
560,500
+512,500
| +1,068% | +$9.96M |
|
2746
BGC Group
BGC
$5.75B
| $10.8M | ﹤0.01% |
1,907,053
+652,460
| +52% | +$3.73M |
|
2747
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.44B
| $10.8M | ﹤0.01% |
309,264
+140,344
| +83% | +$4.81M |
|
2748
CALL
Kinross Gold
KGC
$38.6B
| $10.8M | ﹤0.01% |
1,701,300
+17,200
| +1% | +$128K |
|
2749
PUT
Conagra Brands
CAG
$7.69B
| $10.8M | ﹤0.01% |
296,900
+110,700
| +59% | +$4.14M |
|
2750
PUT
Hewlett Packard
HPE
$72B
| $10.8M | ﹤0.01% |
740,500
+28,400
| +4% | +$449K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.